Bechstedt Natalie, Pomjanski Natalia, Schramm Martin, Remmerbach Torsten W
Department of Oral and Maxillofacial and Facial Plastic Surgery, Section of Clinical and Experimental Oral Medicine, University Hospital Leipzig, Liebigstraße 10-14, 04103 Leipzig, Germany.
Department of Cytopathology, Institute of Pathology, Heinrich Heine University, 40225 Düsseldorf, Germany.
Cancers (Basel). 2022 Nov 26;14(23):5828. doi: 10.3390/cancers14235828.
The accuracy of DNA image cytometry as an investigation method for potentially malignant disorders of the oral cavity is currently still a subject of controversy, due to inconsistently applied definitions of DNA aneuploidy, small cohorts and different application techniques of the method. The aim of this study was to examine the accuracy of the method as a supplementary diagnostic tool in addition to the cytological examination using internationally consented definitions for DNA aneuploidy.
A total of 602 samples from 467 patients with various oral lesions were included in this prospective study. Brush biopsies from each patient were first cytologically examined and categorized by a pathologist, second evaluated using DNA image cytometry, and finally compared to either histological biopsy result or clinical outcome.
Using the standard definition of DNA aneuploidy, we achieved a sensitivity of 93.5%, a positive predictive value for the detection of malignant cells of 98.0%, and an area under the curve of 0.96 of DNA ploidy analysis for the detection of severe oral epithelial dysplasia, carcinoma in situ or oral squamous cell carcinoma. Importantly, using logistic regression and a two-step model, we were able to describe the increased association between DNA-ICM and the detection of malignant cells (OR = 201.6) as a secondary predictor in addition to cytology (OR = 11.90).
In summary, this study has shown that DNA ploidy analysis based on conventional specimens of oral brush biopsies is a highly sensitive, non-invasive, patient-friendly method that should be considered as an additional diagnostic tool for detecting malignant changes in the oral cavity.
由于DNA非整倍体的定义应用不一致、队列规模小以及该方法的应用技术不同,DNA图像细胞术作为口腔潜在恶性疾病的一种检测方法,其准确性目前仍是一个有争议的话题。本研究的目的是使用国际公认的DNA非整倍体定义,检验该方法作为细胞学检查之外的辅助诊断工具的准确性。
本前瞻性研究纳入了467例患有各种口腔病变患者的602份样本。首先由病理学家对每位患者的刷检活检样本进行细胞学检查并分类,其次使用DNA图像细胞术进行评估,最后将结果与组织学活检结果或临床结局进行比较。
采用DNA非整倍体的标准定义,我们在检测重度口腔上皮发育异常、原位癌或口腔鳞状细胞癌时,DNA倍体分析的灵敏度达到93.5%,检测恶性细胞的阳性预测值为98.0%,曲线下面积为0.96。重要的是,使用逻辑回归和两步模型,我们能够描述除细胞学检查(比值比=11.90)外,DNA图像细胞术与恶性细胞检测之间增加的关联(比值比=201.6),作为次要预测指标。
总之,本研究表明,基于口腔刷检活检常规样本的DNA倍体分析是一种高度敏感、非侵入性、对患者友好的方法,应被视为检测口腔恶性病变的一种额外诊断工具。